中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A new eudesmane sesquiterpenoid lactone from Chloranthus japonicus

文献类型:期刊论文

作者Fang Ping-Lei; Liu Hai-Yang; Zhong Hui-Min
刊名CHINESE JOURNAL OF NATURAL MEDICINES
出版日期2012
卷号10期号:1页码:24-27
关键词Acute Promyelocytic Leukemia Activated Protein-kinase Retinoic Acid Signal-transduction Alpha Oncoprotein Pmlrar-alpha C/ebp-beta Product Stress H2o2
ISSN号1672-3651
DOI10.3724/SP.J.1009.2012.00024
通讯作者Liu, HY (reprint author), Chinese Acad Sci, State Key Lab Phytochem & Plant Resources W China, Kunming Inst Bot, Kunming 650204, Peoples R China, haiyangliu@mail.kib.ac.cn
文献子类Article
英文摘要AIM: To study the chemical constituents of the whole plant of Chloranthus japonicus. METHODS: Compounds were isolated and purified by column chromatography. Their structures were elucidated on the basis of spectroscopic methods. RESULTS: Six sesquiterpenoids were obtained and their structures were identified as chlojaponilactone A (1), atractylenolide III (2), neolitacumone B (3), 10 alpha-hydroxy-1-oxoeremophila-7(11), 8(9)-diene-8, 12-olide (4), shizukanolide C (5), and shizukanolide H (6). CONCLUSION: Compound 1 is a new eudesmane-type sesquiterpenoid lactone, and compounds 3 and 4 have been isolated from this species for the first time.
WOS研究方向Integrative & Complementary Medicine ; Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000299067400005
公开日期2012-06-07
源URL[http://ir.kib.ac.cn:8080/handle/151853/10343]  
专题昆明植物研究所_植物化学与西部植物资源持续利用国家重点实验室
推荐引用方式
GB/T 7714
Fang Ping-Lei,Liu Hai-Yang,Zhong Hui-Min. A new eudesmane sesquiterpenoid lactone from Chloranthus japonicus[J]. CHINESE JOURNAL OF NATURAL MEDICINES,2012,10(1):24-27.
APA Fang Ping-Lei,Liu Hai-Yang,&Zhong Hui-Min.(2012).A new eudesmane sesquiterpenoid lactone from Chloranthus japonicus.CHINESE JOURNAL OF NATURAL MEDICINES,10(1),24-27.
MLA Fang Ping-Lei,et al."A new eudesmane sesquiterpenoid lactone from Chloranthus japonicus".CHINESE JOURNAL OF NATURAL MEDICINES 10.1(2012):24-27.

入库方式: OAI收割

来源:昆明植物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。